These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24875071)

  • 1. Effect of methylphenidate on neurocognitive test battery: an evaluation according to the diagnostic and statistical manual of mental disorders, fourth edition, subtypes.
    Durak S; Ercan ES; Ardic UA; Yuce D; Ercan E; Ipci M
    J Clin Psychopharmacol; 2014 Aug; 34(4):467-74. PubMed ID: 24875071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder.
    Huang YS; Chao CC; Wu YY; Chen YY; Chen CK
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):219-25. PubMed ID: 17472588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
    Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When does it end? Attention-deficit/hyperactivity disorder in the middle aged and older populations.
    Manor I; Rozen S; Zemishlani Z; Weizman A; Zalsman G
    Clin Neuropharmacol; 2011; 34(4):148-54. PubMed ID: 21738027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
    Rhodes SM; Coghill DR; Matthews K
    J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate improves Stroop naming speed, but not response interference, in children with attention deficit hyperactivity disorder.
    Bedard AC; Ickowicz A; Tannock R
    J Child Adolesc Psychopharmacol; 2002; 12(4):301-9. PubMed ID: 12625990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of methylphenidate on the power spectrum of ADHD children - an MEG study.
    Wienbruch C; Paul I; Bauer S; Kivelitz H
    BMC Psychiatry; 2005 Jul; 5():29. PubMed ID: 16042816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J; Pliszka SR
    J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel strategy for the analysis of CPT data provides new insight into the effects of methylphenidate on attentional states in children with ADHD.
    Teicher MH; Lowen SB; Polcari A; Foley M; McGreenery CE
    J Child Adolesc Psychopharmacol; 2004; 14(2):219-32. PubMed ID: 15319019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of methylphenidate on various components of visual attention in children with attention-deficit hyperactivity disorder].
    Durukan I; Türkbay T; Cöngöloğlu A
    Turk Psikiyatri Derg; 2008; 19(4):358-64. PubMed ID: 19110977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in attentional performance and their modulation by methylphenidate in children with attention-deficit/hyperactivity disorder.
    Günther T; Herpertz-Dahlmann B; Konrad K
    J Child Adolesc Psychopharmacol; 2010 Jun; 20(3):179-86. PubMed ID: 20578930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of methylphenidate on Stroop Color-Word task performance in children with attention deficit hyperactivity disorder.
    Langleben DD; Monterosso J; Elman I; Ash B; Krikorian G; Austin G
    Psychiatry Res; 2006 Mar; 141(3):315-20. PubMed ID: 16516306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Executive impairment determines ADHD medication response: implications for academic achievement.
    Hale JB; Reddy LA; Semrud-Clikeman M; Hain LA; Whitaker J; Morley J; Lawrence K; Smith A; Jones N
    J Learn Disabil; 2011; 44(2):196-212. PubMed ID: 21383110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
    Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
    Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity but not comorbidities predicts response to methylphenidate in adults with attention-deficit/hyperactivity disorder: results from a naturalistic study.
    Victor MM; Rovaris DL; Salgado CA; Silva KL; Karam RG; Vitola ES; Picon FA; Contini V; Guimarães-da-Silva PO; Blaya-Rocha P; Belmonte-de-Abreu PS; Rohde LA; Grevet EH; Bau CH
    J Clin Psychopharmacol; 2014 Apr; 34(2):212-7. PubMed ID: 24577256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylphenidate-osmotic-controlled release oral delivery system treatment reduces parenting stress in parents of children and adolescents with attention-deficit/hyperactivity disorder.
    Hwang JW; Kim B; Kim Y; Kim TH; Seo WS; Shin DW; Woo YJ; Yoo H; Lee JS; Lee JH; Lim MH; Chung YC; Jung CH; Yoo HK
    Hum Psychopharmacol; 2013 Nov; 28(6):600-7. PubMed ID: 24519694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder.
    O'Driscoll GA; Dépatie L; Holahan AL; Savion-Lemieux T; Barr RG; Jolicoeur C; Douglas VI
    Biol Psychiatry; 2005 Jun; 57(11):1452-60. PubMed ID: 15950020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Israel Survey of Mental Health among Adolescents: prevalence of attention-deficit/hyperactivity disorder, comorbidity, methylphenidate use, and help-seeking patterns.
    Farbstein I; Mansbach-Kleinfeld I; Auerbach JG; Ponizovsky AM; Apter A
    Isr Med Assoc J; 2014 Sep; 16(9):568-73. PubMed ID: 25351015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.